Citigroup Maintains Neutral on GE HealthCare Techs, Lowers Price Target to $65

Citigroup analyst Joanne Wuensch maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and lowers the price target from $80 to $65.